C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 20.5 NOK 2.5% Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Carasent ASA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carasent ASA
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Total Equity
kr935m
CAGR 3-Years
6%
CAGR 5-Years
60%
CAGR 10-Years
22%
N
Nordhealth AS
OSE:NORDH
Total Equity
€82.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Total Equity
kr95.3m
CAGR 3-Years
-27%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
19.95 NOK
Overvaluation 3%
Intrinsic Value
Price
C

See Also

What is Carasent ASA's Total Equity?
Total Equity
935m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Total Equity amounts to 935m NOK.

What is Carasent ASA's Total Equity growth rate?
Total Equity CAGR 10Y
22%

Over the last year, the Total Equity growth was -22%. The average annual Total Equity growth rates for Carasent ASA have been 6% over the past three years , 60% over the past five years , and 22% over the past ten years .

Back to Top